Table 2. Prevalence of MetS and its components among cancer survivors.
| Variables | Total, N (%) | Gender | ||
|---|---|---|---|---|
| Male, n (%) | Female, n (%) | p | ||
| Metabolic syndrome | 30 (34.1) | 17 (27.0) | 13 (52.0) | 0.026 |
| WC >90 cm in men and >80 cm in women | 29 (33.0) | 17 (27.0) | 12 (48.0) | 0.059 |
| Triglyceride levels 80 mg/dL or medication use | 18 (20.5) | 9 (14.3) | 9 (36.0) | 0.023 |
| HDL cholesterol levels <40 mg/dL in men and <50 mg/dL in women or medication use | 25 (28.4) | 13 (20.6) | 12 (48.0) | 0.010 |
| BP ≥130/85 mmHg or antihypertensive medication use | 36 (40.9) | 22 (34.9) | 14 (56.0) | 0.070 |
| FBS levels 100 mg/dL or medication use (insulin or oral agents) | 68 (77.3) | 49 (71.6) | 19 (76.0) | 0.858 |
WC: waist circumference, TG: triglyceride, HDL: high-density lipoprotein, HTN: hypertension, FBS: fasting blood sugar